Patrick O. Byrne

3.0k total citations
17 papers, 876 citations indexed

About

Patrick O. Byrne is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Patrick O. Byrne has authored 17 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Epidemiology and 4 papers in Oncology. Recurrent topics in Patrick O. Byrne's work include HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Respiratory viral infections research (3 papers). Patrick O. Byrne is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Respiratory viral infections research (3 papers). Patrick O. Byrne collaborates with scholars based in United States, Switzerland and Italy. Patrick O. Byrne's co-authors include Daniel J. Leahy, Kalina Hristova, Sarvenaz Sarabipour, Anatoly Kiyatkin, Christopher C. Valley, Jason S. McLellan, Kathryn M. Ferguson, Daniel M. Freed, Mark A. Lemmon and Emanuel Salazar-Cavazos and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Patrick O. Byrne

17 papers receiving 865 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick O. Byrne United States	12	553	231	181	74	74	17	876
Mhairi Skinner Canada	10	551 1.0×	160 0.7×	73 0.4×	129 1.7×	126 1.7×	28	888
Haiying Hang China	20	849 1.5×	182 0.8×	103 0.6×	50 0.7×	28 0.4×	57	1.2k
Mayumi Ishihara United States	18	728 1.3×	66 0.3×	105 0.6×	56 0.8×	52 0.7×	35	1.1k
Hitto Kaufmann Germany	14	1.2k 2.2×	160 0.7×	111 0.6×	131 1.8×	36 0.5×	25	1.6k
Yonka Christova United Kingdom	12	834 1.5×	191 0.8×	62 0.3×	34 0.5×	30 0.4×	18	1.2k
Leyma P. De Haro United States	7	1.3k 2.3×	379 1.6×	84 0.5×	58 0.8×	22 0.3×	10	1.5k
Guo Ci Teo United States	12	926 1.7×	143 0.6×	59 0.3×	41 0.6×	24 0.3×	13	1.2k
James P. Koch United States	13	659 1.2×	281 1.2×	62 0.3×	43 0.6×	16 0.2×	19	1.1k
Takuo Suzuki Japan	14	493 0.9×	98 0.4×	299 1.7×	31 0.4×	16 0.2×	23	774

Countries citing papers authored by Patrick O. Byrne

Since Specialization

Citations

This map shows the geographic impact of Patrick O. Byrne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick O. Byrne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick O. Byrne more than expected).

Fields of papers citing papers by Patrick O. Byrne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick O. Byrne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick O. Byrne. The network helps show where Patrick O. Byrne may publish in the future.

Co-authorship network of co-authors of Patrick O. Byrne

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick O. Byrne. A scholar is included among the top collaborators of Patrick O. Byrne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick O. Byrne. Patrick O. Byrne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

McCool, Ryan S., Abigail E. Powell, Daniel J Stieh, et al.. (2026). Structure and immunogenicity of an engineered soluble prefusion-stabilized EBV gB antigen. Nature Communications. 17(1). 1197–1197. 1 indexed citations

Byrne, Patrick O., Alison G. Lee, Jory A. Goldsmith, et al.. (2024). Structure-based design of a soluble human cytomegalovirus glycoprotein B antigen stabilized in a prefusion-like conformation. Proceedings of the National Academy of Sciences. 121(37). e2404250121–e2404250121. 16 indexed citations

Byrne, Patrick O., Brian E. Fisher, David R. Ambrozak, et al.. (2024). Prefusion stabilization of the Hendra and Langya virus F proteins. Journal of Virology. 98(2). e0137223–e0137223. 11 indexed citations

Byrne, Patrick O., Brian E. Fisher, David R. Ambrozak, et al.. (2023). Structural basis for antibody recognition of vulnerable epitopes on Nipah virus F protein. Nature Communications. 14(1). 1494–1494. 20 indexed citations

Wu, Shannon S., Michael A. Fritz, Jamie A. Ku, et al.. (2023). Rates of osteoradionecrosis in resected oral cavity cancer reconstructed with free tissue transfer in the intensity‐modulated radiotherapy era. Head & Neck. 45(4). 890–899. 5 indexed citations

Noton, Sarah L., et al.. (2022). Distinctive features of the respiratory syncytial virus priming loop compared to other non-segmented negative strand RNA viruses. PLoS Pathogens. 18(6). e1010451–e1010451. 11 indexed citations

Byrne, Patrick O. & Jason S. McLellan. (2022). Principles and practical applications of structure-based vaccine design. Current Opinion in Immunology. 77. 102209–102209. 30 indexed citations

González-Magaldi, Mónica, et al.. (2022). Activity of EGFR transmembrane region variants indicates specific transmembrane dimers are not required for EGFR activity. Biochemical Journal. 479(24). 2465–2475. 5 indexed citations

Schaub, Jeffrey M., Chia‐Wei Chou, Kamyab Javanmardi, et al.. (2021). Expression and characterization of SARS-CoV-2 spike proteins. Nature Protocols. 16(11). 5339–5356. 32 indexed citations

10.

Ahmadmehrabi, Shadi, Deborah X. Xie, Bryan K. Ward, Paul C. Bryson, & Patrick O. Byrne. (2021). OHNS Residency Program and Applicant Social Media Presence During the COVID-19 Pandemic. Annals of Otology Rhinology & Laryngology. 130(8). 961–965. 14 indexed citations

11.

Pino, Paco, Joeri Kint, Divor Kiseljak, et al.. (2020). Trimeric SARS-CoV-2 Spike Proteins Produced from CHO Cells in Bioreactors Are High-Quality Antigens. Processes. 8(12). 1539–1539. 11 indexed citations

12.

Byrne, Patrick O., Kalina Hristova, & Daniel J. Leahy. (2020). EGFR forms ligand-independent oligomers that are distinct from the active state. Journal of Biological Chemistry. 295(38). 13353–13362. 26 indexed citations

13.

Freed, Daniel M., Nicholas J. Bessman, Anatoly Kiyatkin, et al.. (2017). EGFR Ligands Differentially Stabilize Receptor Dimers to Specify Signaling Kinetics. Cell. 171(3). 683–695.e18. 264 indexed citations

14.

King, Christopher, Sarvenaz Sarabipour, Patrick O. Byrne, Daniel J. Leahy, & Kalina Hristova. (2014). The FRET Signatures of Noninteracting Proteins in Membranes: Simulations and Experiments. Biophysical Journal. 106(6). 1309–1317. 76 indexed citations

15.

Kavran, Jennifer M., Patrick O. Byrne, Zhihong Wang, et al.. (2014). How IGF-1 activates its receptor. eLife. 3. 146 indexed citations

16.

Liu, Ping, Thomas E. Cleveland, Samuel Bouyain, et al.. (2012). A single ligand is sufficient to activate EGFR dimers. Proceedings of the National Academy of Sciences. 109(27). 10861–10866. 102 indexed citations

17.

Xu, Yu, Richard M. Alvey, Patrick O. Byrne, et al.. (2010). Expression of Genes in Cyanobacteria: Adaptation of Endogenous Plasmids as Platforms for High-Level Gene Expression in Synechococcus sp. PCC 7002. Methods in molecular biology. 684. 273–293. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact